CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 27(Granted Patents)

Company Filing History:

15 out of 134

Ligand Pharmaceuticals, Inc.

patents

3 out of 44

Novira Therapeutics, Inc.

patents

Years Active: 2006-2023

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11773110 - Heterocycle amines and uses thereof (2023-10-03),

2. 11413274 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2022-08-16),

3. 11186593 - Heterocycle amines and uses thereof (2021-11-30),

4. 10736875 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2020-08-11),

5. 10710959 - Sulfide alkyl compounds for HBV treatment (2020-07-14),

6. 10604533 - Heterocycle amines and uses thereof (2020-03-31),

7. 10196351 - Sulfide alkyl compounds for HBV treatment (2019-02-05),

8. 10111859 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2018-10-30),

9. 10030034 - Heterocycle amines and uses thereof (2018-07-24),

10. 9622991 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2017-04-18),

11. 9597332 - Sulfide alkyl compounds for HBV treatment (2017-03-21),

12. 9492430 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2016-11-15),

13. 9266874 - Heterocycle amines and uses thereof (2016-02-23),

14. 9144557 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2015-09-29),

15. 8580811 - Androgen receptor modulator methods (2013-11-12),

Title: **Innovative Contributions of Bijan Pedram in Chemistry and Medicine**

Introduction

Bijan Pedram is a prominent inventor based in San Diego, California, known for his significant contributions to the fields of chemistry and medicine. With an impressive portfolio of 18 patents, his work emphasizes novel compounds and methodologies that address medicinal challenges, particularly in the treatment of inflammatory and neurological disorders.

Latest Patents

Pedram's latest patents reveal his focused efforts in developing heterocycle amines and their applications. One noteworthy patent discloses various compounds, compositions, and methodologies involving heterocycle amines, which show promise in treating inflammatory disorders. Another innovation pertains to methods and compositions that interact with the granulocyte colony-stimulating factor receptor (GCSFR). These embodiments include means to identify compounds that modulate GCSFR activity, providing potential treatments for hematopoietic and neurological disorders.

Career Highlights

Throughout his career, Bijan Pedram has collaborated with leading companies such as Ligand Pharmaceuticals, Inc. and Novira Therapeutics, Inc. His work has been pivotal in advancing research in pharmacology and therapeutics, leveraging his expertise to push the boundaries of what is achievable in drug development and innovative treatments.

Collaborations

Collaboration has been a cornerstone of Pedram's success. He has had the opportunity to work alongside notable professionals, including Lin Zhi and Cornelis Arjan Van Oeveren. These partnerships have enabled the integration of diverse scientific insights, enhancing the effectiveness and applicability of the inventions developed.

Conclusion

Bijan Pedram continues to make a lasting impact in the realms of chemistry and medicine through his inventive spirit and dedication to addressing complex health issues. With a solid foundation of patents and collaborations, his journey as an inventor illustrates the importance of innovation in advancing therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.